↓ Skip to main content

Adverse reactions after treatment with dasatinib in chronic myeloid leukemia: Characteristics, potential mechanisms, and clinical management strategies

Overview of attention for article published in Frontiers in oncology, February 2023
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (63rd percentile)
  • High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

twitter
6 X users

Readers on

mendeley
17 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Adverse reactions after treatment with dasatinib in chronic myeloid leukemia: Characteristics, potential mechanisms, and clinical management strategies
Published in
Frontiers in oncology, February 2023
DOI 10.3389/fonc.2023.1113462
Pubmed ID
Authors

Fang Cheng, Qiling Xu, Qiang Li, Zheng Cui, Weiming Li, Fang Zeng

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 17 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 17 100%

Demographic breakdown

Readers by professional status Count As %
Lecturer 2 12%
Student > Ph. D. Student 2 12%
Student > Bachelor 2 12%
Unspecified 1 6%
Student > Doctoral Student 1 6%
Other 2 12%
Unknown 7 41%
Readers by discipline Count As %
Nursing and Health Professions 4 24%
Biochemistry, Genetics and Molecular Biology 2 12%
Medicine and Dentistry 2 12%
Engineering 1 6%
Unknown 8 47%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 February 2023.
All research outputs
#8,544,090
of 25,394,764 outputs
Outputs from Frontiers in oncology
#3,366
of 22,436 outputs
Outputs of similar age
#161,038
of 473,445 outputs
Outputs of similar age from Frontiers in oncology
#148
of 1,403 outputs
Altmetric has tracked 25,394,764 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,436 research outputs from this source. They receive a mean Attention Score of 3.0. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 473,445 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.
We're also able to compare this research output to 1,403 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.